Latest total current liabilities for VPHIF: $70M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Valeo Pharma (VPHIF) currently reports a total current liabilities of $70M as of July 2024. That compares with $16M in the prior-year period — up 328.2% year over year. Use the charts on this page to explore Valeo Pharma's total current liabilities history and peer comparisons.
Valeo Pharma's total current liabilities increased from $16M to $70M — a 328.2% year-over-year increase (period ending July 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Valeo Pharma reported $70M in total current liabilities as of July 2024. That compares with $16M in the prior-year period — up 328.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $70M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Valeo Pharma, and consider following VPHIF for alerts when major investors trade the stock.